M&A Deal Summary

Cresco Labs Acquires Laurel Harvest Labs

On October 14, 2021, Cresco Labs acquired e-commerce company Laurel Harvest Labs for 80M USD

Acquisition Highlights
  • This is Cresco Labs’ 1st transaction in the E-Commerce sector.
  • This is Cresco Labs’ 6th largest (disclosed) transaction.
  • This is Cresco Labs’ 9th transaction in the United States.
  • This is Cresco Labs’ 2nd transaction in Pennsylvania.

M&A Deal Summary
Date 2021-10-14
Target Laurel Harvest Labs
Sector E-Commerce
Buyer(s) Cresco Labs
Deal Type Add-on Acquisition
Deal Value 80M USD

Target

Laurel Harvest Labs

Montgomeryville, Pennsylvania, United States
Laurel Harvest Labs is a full-service marijuana dispensary focused on patient care. The company delivers targeted medicinal cannabis products to Pennsylvania’s patients. It advances the science around cannabis to produce cutting-edge research with Temple and ultimately increase the efficacy of therapies and patient outcomes. Laurel Harvest Labs was formed in 2020 and is based in Montgomeryville, Pennsylvania.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cresco Labs

Chicago, Illinois, United States
Category Company
Founded 2013
Sector Retail
DESCRIPTION

Cresco Labs LLC is a grower, processor and retailer of premium cannabis with operations in six states (IL, OH, PA, NV, CA and AZ), the company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry.

DEAL STATS #
Overall 10 of 11
Sector (E-Commerce) 1 of 1
Type (Add-on Acquisition) 10 of 11
State (Pennsylvania) 2 of 2
Country (United States) 9 of 10
Year (2021) 6 of 6
Size (of disclosed) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-23 Cure Pennsylvania

Pennsylvania, United States

Cure Pennsylvania is a provider of medical marijuana. Cure Pennsylvania is based in Pennsylvania, United States.

Buy $90M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-23 Columbia Care

New York, New York, United States

Columbia Care is an experienced cultivator, manufacturer, and provider of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. It is an original multi-state provider of medical cannabis in the U.S. and now delivers products and services to both the medical and adult-use markets. In 2021, Columbia Care launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. Columbia Care was founded in 2012 and is based in New York, New York.

Buy -
Mergr

Product

Company

Legal